Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value ($000): $191,825 (100.0% shares, 0.0% debt)

Holdings (13)

BBIO BridgeBio (BBIO) 42.9%

Value ($000) $82,353 Shares 3,835,722 Est. Cost $27.26 Unrealized +1.5%

— Eidos Therapeutics, Inc. (EIDIX) 21.1%

Value ($000) $40,417 Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 6.6%

Value ($000) $12,610 Shares 893,079 Est. Cost $16.87 Unrealized —

— ObsEva SA (OBSV) 6.0%

Value ($000) $11,548 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 5.3%

Value ($000) $10,220 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 5.2%

Value ($000) $9,929 Shares 1,291,151 Est. Cost $7.61 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 3.8%

Value ($000) $7,272 Shares 10,100,000 Est. Cost $0.89 Unrealized —

— Atreca (BCEL) 2.5%

Value ($000) $4,745 Shares 387,653 Est. Cost $18.84 Unrealized —

— Nabriva Therapeutics plc (NBRV) 2.0%

Value ($000) $3,821 Shares 1,910,287 Est. Cost $1.49 Unrealized —

— Zosano Pharma Corporation (ZSAN) 1.6%

Value ($000) $3,165 Shares 2,028,571 Est. Cost $2.36 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 1.6%

Value ($000) $3,033 Shares 333,333 Est. Cost $11.67 Unrealized -31.2%

— Verona Pharma plc (VRNA) 1.1%

Value ($000) $2,027 Shares 443,596 Est. Cost $9.65 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.4%

Value ($000) $685 Shares 634,455 Est. Cost $10.31 Unrealized -86.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio (BBIO)	3,835,722	$82,353	42.9%	$27.26	+1.5%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$40,417	21.1%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	893,079	$12,610	6.6%	$16.87	—	COM	05455M100
—	ObsEva SA (OBSV)	1,386,338	$11,548	6.0%	$12.66	—	COM	H5861P103
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$10,220	5.3%	$5.55	—	COM	57055L107
—	Aeglea Biotherapeutics Inc (AGLE)	1,291,151	$9,929	5.2%	$7.61	—	COM	00773J103
—	Sunesis Pharmaceuticals, Inc. (SNSS)	10,100,000	$7,272	3.8%	$0.89	—	COM	867328700
—	Atreca (BCEL)	387,653	$4,745	2.5%	$18.84	—	CL A COM	04965G109
—	Nabriva Therapeutics plc (NBRV)	1,910,287	$3,821	2.0%	$1.49	—	SHS	G63637105
—	Zosano Pharma Corporation (ZSAN)	2,028,571	$3,165	1.6%	$2.36	—	COM	98979H202
RCUS	Arcus Biosciences, Inc. (RCUS)	333,333	$3,033	1.6%	$11.67	-31.2%	COM	03969F109
—	Verona Pharma plc (VRNA)	443,596	$2,027	1.1%	$9.65	—	COM	925050106
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$685	0.4%	$10.31	-86.2%	COM	00461U105